Article
Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study.
International journal of cancer - 1 Jan 2012
Johansson Mattias, Holmström Benny, Hinchliffe Sally R, Bergh Anders, Stenman Ulf-Håkan, Hallmans Göran, Wiklund Fredrik, Stattin Pär
Abstract excerpt
The aim of this study was to investigate if a genetic risk score including 33 common genetic variants improves prediction of prostate cancer when added to measures of prostate-specific antigen (PSA). We conducted a case-control study nested within the Northern Sweden Health and Disease Cohort (NSHDC), a prospective cohort in northern Sweden. A total of 520 cases and 988 controls matched for age, and date of blood...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
